Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.5K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

685
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
685
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Large reasoning models as thinking machines for medicine.

Nature biomedical engineering·2026
Same author

Diabetic retinal disease cure accelerator: Modernizing staging and endpoints.

Progress in retinal and eye research·2026
Same author

AI-induced never-skilling in medical education.

Nature medicine·2026
Same author

Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist.

Eye (London, England)·2026
Same author

Modifiable Factors Associated with Diabetic Retinal Disease and Retinal Neural Layer Thickness in Youth with Type 1 Diabetes.

Ophthalmology·2026
Same author

Patient and staff experiences of a community-based diagnostic clinic for chronic eye conditions: Qualitative analysis.

Eye (London, England)·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 9, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.2K

糖尿病性網膜疾患

Sobha Sivaprasad1,2, Tien Yin Wong3,4, Thomas W Gardner5

  • 1National Institute of Health Research Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK. sobha.sivaprasad@nhs.net.

Nature reviews. Disease primers
|August 28, 2025
PubMed
まとめ
この要約は機械生成です。

糖尿病性網膜疾患は 血管だけでなく 網膜全体に影響します 視力を改善し 失明を減らすために 個別化されたスクリーニング,治療,DRDのモニタリングが進んでいます

さらに関連する動画

Retinal Pathophysiological Evaluation in a Rat Model
09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

4.7K
Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Published on: December 26, 2017

13.5K

関連する実験動画

Last Updated: Sep 9, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.2K
Retinal Pathophysiological Evaluation in a Rat Model
09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

4.7K
Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Published on: December 26, 2017

13.5K

科学分野:

  • 眼科について
  • 内分泌学
  • 糖尿病について

背景:

  • 糖尿病性網膜病 (DRD) と呼ばれる 糖尿病性網膜病は ニューロンや膠質を含む網膜全体に 影響を及ぼし 微小血管系に 変化をもたらします
  • 糖尿病は網膜の健康に大きく影響し,視覚の鋭さや生活の質に影響します.

研究 の 目的:

  • DRDの前臨床的および臨床的徴候に関する研究を統合する.
  • DRDの症状と視覚の鋭さと患者の報告したアウトカムを関連付けること.
  • 糖尿病患者の全身の健康と代謝因子をDRDの特徴と統合する.

主な方法:

  • 糖尿病性網膜症臨床研究ネットワークの試験やその他の研究から得られたデータを活用する.
  • 増殖性糖尿病性網膜症と糖尿病性黄斑腫を含む,視力を脅かすDRDの現在の管理戦略の評価
  • 費用対効果の高い 個別化されたスクリーニング,治療,モニタリング戦略の開発と評価

主要な成果:

  • 視力を脅かすDRDの現在の管理のための実質的な証拠が存在する.
  • パーソナライズされたDRDの管理にはAIが組み込まれています
  • 新しい治療法と投与方法が 耐久性や手頃な価格の改善のために 評価されている.

結論:

  • 継続的な世界的な取り組みは,DRDをより良く理解し管理することを目的としています.
  • AIと新しい治療法の進歩は 患者の治療成果を向上させ 世界的な失明の負担を軽減することを約束しています
  • パーソナライズされたアプローチは 糖尿病患者の視覚関連の生活の質を向上させる鍵です